Cargando…

Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project

BACKGROUND: Use of electronic clinical trial portals has increased in recent years to assist with sponsor-investigator communication, safety reporting, and clinical trial management. Electronic portals can help reduce time and costs associated with processing paperwork and add security measures; how...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Raymond P, Finnigan, Shanda, Patel, Krupa, Whitney, Shanell, Forrest, Annemarie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367842/
https://www.ncbi.nlm.nih.gov/pubmed/28410179
http://dx.doi.org/10.2196/cancer.6701
_version_ 1782517844777369600
author Perez, Raymond P
Finnigan, Shanda
Patel, Krupa
Whitney, Shanell
Forrest, Annemarie
author_facet Perez, Raymond P
Finnigan, Shanda
Patel, Krupa
Whitney, Shanell
Forrest, Annemarie
author_sort Perez, Raymond P
collection PubMed
description BACKGROUND: Use of electronic clinical trial portals has increased in recent years to assist with sponsor-investigator communication, safety reporting, and clinical trial management. Electronic portals can help reduce time and costs associated with processing paperwork and add security measures; however, there is a lack of information on clinical trial investigative staff’s perceived challenges and benefits of using portals. OBJECTIVE: The Clinical Trials Transformation Initiative (CTTI) sought to (1) identify challenges to investigator receipt and management of investigational new drug (IND) safety reports at oncologic investigative sites and coordinating centers and (2) facilitate adoption of best practices for communicating and managing IND safety reports using electronic portals. METHODS: CTTI, a public-private partnership to improve the conduct of clinical trials, distributed surveys and conducted interviews in an opinion-gathering effort to record investigator and research staff views on electronic portals in the context of the new safety reporting requirements described in the US Food and Drug Administration’s final rule (Code of Federal Regulations Title 21 Section 312). The project focused on receipt, management, and review of safety reports as opposed to the reporting of adverse events. RESULTS: The top challenge investigators and staff identified in using individual sponsor portals was remembering several complex individual passwords to access each site. Also, certain tasks are time-consuming (eg, downloading reports) due to slow sites or difficulties associated with particular operating systems or software. To improve user experiences, respondents suggested that portals function independently of browsers and operating systems, have intuitive interfaces with easy navigation, and incorporate additional features that would allow users to filter, search, and batch safety reports. CONCLUSIONS: Results indicate that an ideal system for sharing expedited IND safety information is through a central portal used by all sponsors. Until this is feasible, electronic reporting portals should at least have consistent functionality. CTTI has issued recommendations to improve the quality and use of electronic portals.
format Online
Article
Text
id pubmed-5367842
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-53678422017-04-14 Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project Perez, Raymond P Finnigan, Shanda Patel, Krupa Whitney, Shanell Forrest, Annemarie JMIR Cancer Original Paper BACKGROUND: Use of electronic clinical trial portals has increased in recent years to assist with sponsor-investigator communication, safety reporting, and clinical trial management. Electronic portals can help reduce time and costs associated with processing paperwork and add security measures; however, there is a lack of information on clinical trial investigative staff’s perceived challenges and benefits of using portals. OBJECTIVE: The Clinical Trials Transformation Initiative (CTTI) sought to (1) identify challenges to investigator receipt and management of investigational new drug (IND) safety reports at oncologic investigative sites and coordinating centers and (2) facilitate adoption of best practices for communicating and managing IND safety reports using electronic portals. METHODS: CTTI, a public-private partnership to improve the conduct of clinical trials, distributed surveys and conducted interviews in an opinion-gathering effort to record investigator and research staff views on electronic portals in the context of the new safety reporting requirements described in the US Food and Drug Administration’s final rule (Code of Federal Regulations Title 21 Section 312). The project focused on receipt, management, and review of safety reports as opposed to the reporting of adverse events. RESULTS: The top challenge investigators and staff identified in using individual sponsor portals was remembering several complex individual passwords to access each site. Also, certain tasks are time-consuming (eg, downloading reports) due to slow sites or difficulties associated with particular operating systems or software. To improve user experiences, respondents suggested that portals function independently of browsers and operating systems, have intuitive interfaces with easy navigation, and incorporate additional features that would allow users to filter, search, and batch safety reports. CONCLUSIONS: Results indicate that an ideal system for sharing expedited IND safety information is through a central portal used by all sponsors. Until this is feasible, electronic reporting portals should at least have consistent functionality. CTTI has issued recommendations to improve the quality and use of electronic portals. JMIR Publications 2016-12-15 /pmc/articles/PMC5367842/ /pubmed/28410179 http://dx.doi.org/10.2196/cancer.6701 Text en ©Raymond P Perez, Shanda Finnigan, Krupa Patel, Shanell Whitney, Annemarie Forrest. Originally published in JMIR Cancer (http://cancer.jmir.org), 15.12.2016. https://creativecommons.org/licenses/by/2.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/ (https://creativecommons.org/licenses/by/2.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cancer, is properly cited. The complete bibliographic information, a link to the original publication on http://cancer.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Perez, Raymond P
Finnigan, Shanda
Patel, Krupa
Whitney, Shanell
Forrest, Annemarie
Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
title Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
title_full Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
title_fullStr Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
title_full_unstemmed Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
title_short Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project
title_sort clinical trial electronic portals for expedited safety reporting: recommendations from the clinical trials transformation initiative investigational new drug safety advancement project
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367842/
https://www.ncbi.nlm.nih.gov/pubmed/28410179
http://dx.doi.org/10.2196/cancer.6701
work_keys_str_mv AT perezraymondp clinicaltrialelectronicportalsforexpeditedsafetyreportingrecommendationsfromtheclinicaltrialstransformationinitiativeinvestigationalnewdrugsafetyadvancementproject
AT finniganshanda clinicaltrialelectronicportalsforexpeditedsafetyreportingrecommendationsfromtheclinicaltrialstransformationinitiativeinvestigationalnewdrugsafetyadvancementproject
AT patelkrupa clinicaltrialelectronicportalsforexpeditedsafetyreportingrecommendationsfromtheclinicaltrialstransformationinitiativeinvestigationalnewdrugsafetyadvancementproject
AT whitneyshanell clinicaltrialelectronicportalsforexpeditedsafetyreportingrecommendationsfromtheclinicaltrialstransformationinitiativeinvestigationalnewdrugsafetyadvancementproject
AT forrestannemarie clinicaltrialelectronicportalsforexpeditedsafetyreportingrecommendationsfromtheclinicaltrialstransformationinitiativeinvestigationalnewdrugsafetyadvancementproject